PROCEPT BioRobotics (PRCT) Competitors $39.57 -0.60 (-1.49%) Closing price 09/2/2025 04:00 PM EasternExtended Trading$40.95 +1.38 (+3.49%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PRCT vs. STVN, IRTC, GKOS, BLCO, TMDX, SLNO, NVST, LIVN, WRBY, and INSPShould you be buying PROCEPT BioRobotics stock or one of its competitors? The main competitors of PROCEPT BioRobotics include Stevanato Group (STVN), iRhythm Technologies (IRTC), Glaukos (GKOS), Bausch + Lomb (BLCO), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Envista (NVST), LivaNova (LIVN), Warby Parker (WRBY), and Inspire Medical Systems (INSP). These companies are all part of the "medical equipment" industry. PROCEPT BioRobotics vs. Its Competitors Stevanato Group iRhythm Technologies Glaukos Bausch + Lomb TransMedics Group Soleno Therapeutics Envista LivaNova Warby Parker Inspire Medical Systems PROCEPT BioRobotics (NASDAQ:PRCT) and Stevanato Group (NYSE:STVN) are both mid-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, valuation, institutional ownership, media sentiment and risk. Do analysts prefer PRCT or STVN? PROCEPT BioRobotics currently has a consensus target price of $73.22, suggesting a potential upside of 85.04%. Given PROCEPT BioRobotics' stronger consensus rating and higher probable upside, analysts clearly believe PROCEPT BioRobotics is more favorable than Stevanato Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PROCEPT BioRobotics 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.89Stevanato Group 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.83 Does the media prefer PRCT or STVN? In the previous week, PROCEPT BioRobotics had 6 more articles in the media than Stevanato Group. MarketBeat recorded 12 mentions for PROCEPT BioRobotics and 6 mentions for Stevanato Group. PROCEPT BioRobotics' average media sentiment score of 1.55 beat Stevanato Group's score of 1.36 indicating that PROCEPT BioRobotics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PROCEPT BioRobotics 10 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Stevanato Group 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger earnings and valuation, PRCT or STVN? Stevanato Group has higher revenue and earnings than PROCEPT BioRobotics. PROCEPT BioRobotics is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPROCEPT BioRobotics$224.50M9.81-$91.41M-$1.55-25.53Stevanato Group€1.19B5.73€127.45M€0.5441.89 Which has more volatility & risk, PRCT or STVN? PROCEPT BioRobotics has a beta of 1.03, meaning that its share price is 3% more volatile than the S&P 500. Comparatively, Stevanato Group has a beta of 0.55, meaning that its share price is 45% less volatile than the S&P 500. Is PRCT or STVN more profitable? Stevanato Group has a net margin of 11.73% compared to PROCEPT BioRobotics' net margin of -30.60%. Stevanato Group's return on equity of 10.34% beat PROCEPT BioRobotics' return on equity.Company Net Margins Return on Equity Return on Assets PROCEPT BioRobotics-30.60% -23.73% -17.34% Stevanato Group 11.73%10.34%6.21% Do insiders & institutionals hold more shares of PRCT or STVN? 89.5% of PROCEPT BioRobotics shares are owned by institutional investors. 17.4% of PROCEPT BioRobotics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. SummaryPROCEPT BioRobotics beats Stevanato Group on 9 of the 17 factors compared between the two stocks. Get PROCEPT BioRobotics News Delivered to You Automatically Sign up to receive the latest news and ratings for PRCT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PRCT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRCT vs. The Competition Export to ExcelMetricPROCEPT BioRoboticsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.23B$7.09B$5.74B$9.77BDividend YieldN/A1.19%6.66%4.50%P/E Ratio-25.5325.3883.1926.39Price / Sales9.8170.48532.40110.52Price / CashN/A22.4425.7028.92Price / Book5.716.9611.096.58Net Income-$91.41M$174.83M$3.28B$265.84M7 Day Performance-3.01%-0.12%-0.21%-0.26%1 Month Performance-20.80%3.72%8.31%5.82%1 Year Performance-47.28%8.72%54.52%22.47% PROCEPT BioRobotics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRCTPROCEPT BioRobotics3.6758 of 5 stars$39.57-1.5%$73.22+85.0%-49.9%$2.23B$224.50M-25.53430Positive NewsAnalyst UpgradeSTVNStevanato GroupN/A€21.99-2.8%N/A+3.4%€6.66B€1.19B40.725,521Positive NewsIRTCiRhythm Technologies1.6083 of 5 stars$165.68-2.0%$162.64-1.8%+141.4%$5.43B$591.84M0.002,000Positive NewsGKOSGlaukos4.7851 of 5 stars$91.78-2.5%$127.42+38.8%-29.8%$5.40B$383.48M-55.62780Positive NewsBLCOBausch + Lomb2.2123 of 5 stars$14.57-2.5%$15.56+6.8%-9.8%$5.29B$4.79B35.5713,500TMDXTransMedics Group3.3224 of 5 stars$114.97-4.1%$123.00+7.0%-33.6%$4.09B$441.54M62.10210Positive NewsGap DownSLNOSoleno Therapeutics4.5604 of 5 stars$66.51-3.0%$115.09+73.0%+37.3%$3.64BN/A-16.0730Positive NewsNVSTEnvista3.7859 of 5 stars$21.15-2.6%$20.92-1.1%+13.3%$3.61B$2.51B25.2612,300News CoveragePositive NewsLIVNLivaNova1.7443 of 5 stars$56.35+0.8%$59.71+6.0%+13.0%$3.05B$1.25B-14.492,900News CoveragePositive NewsWRBYWarby Parker1.7805 of 5 stars$26.18-3.1%$24.06-8.1%+71.6%$2.84B$771.32M-373.883,780Positive NewsGap DownINSPInspire Medical Systems4.9884 of 5 stars$93.20-2.9%$165.62+77.7%-47.4%$2.84B$802.80M41.741,246Positive NewsAnalyst ForecastInsider Trade Related Companies and Tools Related Companies STVN Competitors IRTC Competitors GKOS Competitors BLCO Competitors TMDX Competitors SLNO Competitors NVST Competitors LIVN Competitors WRBY Competitors INSP Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PRCT) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PROCEPT BioRobotics Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share PROCEPT BioRobotics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PRCT Stock Alerts